Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fludrocortisone for Hypotension in Fasting SAI Patients
NCT06832566Phase 4Not yet recruiting
- Sponsor
- Hôpital La Rabta
- Start
- Feb 2025
- Primary completion
- Apr 2025
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of fludrocortisone in hypotension, sponsored by Hôpital La Rabta. Primary endpoint: Number of fasted days at 1 month. Planned start Feb 2025; status: not yet recruiting.
02
Drugs
fludrocortisone
03
Conditions
hypotension
Beyond the preview
Go deeper on NCT06832566.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06832566.